Clomiphene in the Treatment of Adolescent Gynecomastia
Authors:
- Paul V. PlourdePPPaul V. Plourde
- Howard E. KulinHKHoward E. Kulin
- Steven J. SantnerSSSteven J. Santner
- 1 November 1983
- journal article
- research article
- Published by American Medical Association (AMA) in American Journal of Diseases of Children
- Vol. 137 (11) , 1080-1082
Abstract
• Twelve boys, aged 12 to 19 years, with persistent gynecomastia were treated with the antiestrogen, clomiphene citrate, at a dose of 50 mg/day by mouth for one to three months. The mean breast size decreased by 0% to 36%, with only five boys experiencing a reduction of greater than 20%. Five boys subsequently required reduction mammoplasty. Levels of urinary gonadotropins, serum testosterone, and estradiol increased significantly during therapy. Since the ratio of testosterone to estradiol remained unchanged during treatment, the antiestrogen effects were achieved primarily at the level of breast tissue. Clomiphene citrate in a dose of 50 mg/day resulted in only small decreases in persistent pubertal gynecomastia and was not a satisfactory medical therapy for the condition. (Am J Dis Child 1983;137:1080-1082)Keywords
This publication has 5 references indexed in Scilit:
- Adrenal Suppression with Aminoglutethimide. II. Differential Effects of Aminoglutethimide on Plasma Androstenedione and Estrogen Levels12The Journal of Clinical Endocrinology & Metabolism, 1977
- Timed urinary gonadotropin measurements in normal infants, children, and adults, and in patients with disorders of sexual maturationThe Journal of Pediatrics, 1977
- The relationship of concentrations of serum hormones to pubertal gynecomastiaThe Journal of Pediatrics, 1975
- Plasma testosterone and estrogens in pubertal gynecomastiaEuropean Journal of Pediatrics, 1973
- Variations in the Pattern of Pubertal Changes in BoysArchives of Disease in Childhood, 1970